Hence, given the controversy around the efficacy of immunotherapy in diabetics compared to classical treatments, this meta-analysis was conducted to assess the effects of this type of treatment on obtaining the desired changes in C-peptide and HbA1c levels and insulin dose in individuals suffering from T1DM. The gene discussed is INS; the disease is type 1 diabetes mellitus.